Amlin PLC
10 January 2007
AMLIN PLC
PRESS RELEASE
For immediate release
10 January 2007
TRADING STATEMENT
Amlin plc ('Amlin' or 'the Group'), the leading insurer, is today providing an
update on current trading as set out below.
Current trading
2006 underwriting
The Group's gross written premium (after brokerage costs) in the year ended 31
December 2006 was £882 million, up 19% over the same period in 2005.
Syndicate 2001's gross written premium was £783 million (at rates of $1.96:£1),
compared to £744 million for the previous year at comparable rates of exchange.
This includes additional insurance business written for Amlin Bermuda of £28
million. Amlin Bermuda has written $250 million of new premium income for the
Group, including the cessions referred to above but excluding the whole account
reinsurance of Syndicate 2001.
The average renewal rate increase for Syndicate 2001 for the year was 6.25% with
renewal retention at 77%. The rating trends are similar to that reported in
November. The non-marine and marine markets, where the rating environments have
been strongest, have been the growth areas for the Group in the year. Amlin
Bermuda has written mainly reinsurance business, where the rating environment
has been strong, and where Syndicate 2001 experienced some of its largest rate
increases in the year. Within the aviation division pricing on the airline
account remains under pressure and the UK commercial market continues to see
competitive pressure on rates.
2007 underwriting
1 January is a major renewal period for a number of key classes of business for
Amlin. Amlin has written total income to date of £254 million, a 12% increase on
the previous year. The overall renewal rate increase achieved by Amlin across
all classes was 1%. Reinsurance rates remained healthy with average rate
improvements on US catastrophe business of 20% and reductions for international
catastrophe reinsurance rates of 5%. As noted above, Amlin Bermuda's
underwriting is concentrated on reinsurance classes. The company had an
excellent start to the year, and, excluding the whole account reinsurance of
Syndicate 2001, has written $87 million to date, a 58% increase on business
written at this stage last year.
Investment returns
Fourth quarter equity market performance was strong and our equity returns for
the year reached 15%.
Bond market performance in the fourth quarter was poor as the market started to
reduce its expectations of near term rate cuts as US and UK growth remained
robust. For the year the Syndicate short sterling bonds returned 2.5% (H1 2006:
0.8%) and US dollars 3.8% (H1 2006: 0.3%).
The weighted average return on average group cash and investments, of £2.1
billion, was 4.8% for 2006.
Charles Philipps, Chief Executive of Amlin added:
'2006 was an excellent year for Amlin with strong premium growth into a benign
claims environment. 2007 has begun well and we are pleased with the Group's
underwriting position through the important 1 January renewal season.'
Enquiries:
Charles Philipps, Chief Executive, Amlin plc 0207 746 1000
Richard Hextall, Finance Director, Amlin plc 0207 746 1000
Hannah Bale, Head of Communications, Amlin plc 0207 746 1000
David Haggie/Peter Rigby, Haggie Financial 0207 417 8989 / 07768 332486
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.